Pfizer made $19 Billion in Q2 this year, or $211 million per day. Some known risks of their jab are blood clots and cardiomyopathy. Luckily for them they make Eliquis for treating blood clots – sales up 13%. They also make Vyndaqel to treat cardiomyopathy – sales are up 77%!
— COVID FORUM (@ForumCovid) September 20, 2021
Rate this:
Share this:
- Click to share on Twitter (Opens in new window)
- Click to share on Facebook (Opens in new window)
- Click to share on LinkedIn (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on Tumblr (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to share on Pocket (Opens in new window)
- Click to share on Skype (Opens in new window)
- Click to email a link to a friend (Opens in new window)
- Click to print (Opens in new window)
"OUR WORLD" 